Pharma R&D has a reputation for glacial change, but AI could finally force the industry to pivot. According to Deloitte’s 2024 Global Life Sciences Sector Outlook released in late May, only about 16% of drug discovery efforts were using AI, though it projected triple-digit growth over the next few years. “It’s definitely early,” says AION…
This week in AI research: ‘o3’ and reasoning version of ‘Gemini 2.0’ redefine AI capabilities
Long the stuff of sci-fi, humanoid robots are moving from prototypes toward practical use in factories and labs. AI is shifting from massive models toward smarter reasoning — and now Google is getting in the AI reasoning game while OpenAI is teasing the next iteration of its reasoning model. Meanwhile, biotech efforts like comprehensive epigenetic…